Skip to content
compoundwiki.com
Well Researched

Melanotan II

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that stimulates melanin production for skin tanning and has additional effects on sexual arousal and appetite…

View research
Well Researched

MK-677

MK-677 (Ibutamoren) is a selective ghrelin receptor agonist that stimulates growth hormone release without suppressing natural production.

View research
Extensively Studied

MOTS-c

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by the mitochondrial genome.

View research
Extensively Studied

NAD+

Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme found in every cell that plays a crucial role in energy production, DNA repair, and cellular metabolism.

View research

Orforglipron (Foundayo)

Orforglipron (brand name Foundayo) is an FDA-approved oral, non-peptide GLP-1 receptor agonist and the first small-molecule GLP-1 approved for weight management.

View research

PT-141

PT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R receptors in the central nervous system.

View research
Extensively Studied

Retatrutide

Retatrutide (LY3437943) is a novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors.

View research

Semaglutide

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist FDA-approved for type 2 diabetes management (as Ozempic injectable or Rybelsus oral) and chronic weight management (as…

View research
Emerging Research

SLU-PP-332

SLU-PP-332 is a groundbreaking synthetic small-molecule compound developed at Saint Louis University that functions as a pan-estrogen-related receptor (ERR) agonist with preferential activity at ERRα.

View research
Extensively Studied

Survodutide

Survodutide (BI 456906) is an investigational dual glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R) agonist designed for once-weekly subcutaneous administration.

View research

Tesamorelin

Tesamorelin is an FDA-approved synthetic growth hormone-releasing hormone (GHRH) analog designed for treating HIV-associated lipodystrophy.

View research